Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company whose news flow centers on deployments, partnerships, regulatory developments, and capital markets activity related to its SteraMist systems and Binary Ionization Technology (BIT) platform. The company’s announcements highlight how its ionized Hydrogen Peroxide (iHP) technology is integrated into high-stakes environments where contamination control and infection prevention are essential.
Recent news releases describe multi-stage SteraMist iHP implementations at cell and gene therapy manufacturing sites, integration of SteraMist Integrated Systems into critical pharmaceutical manufacturing infrastructure, and installation of a SteraMist Hybrid System in a research university facility for reusable medical product sterilization. TOMI also reports on its role in life sciences and medical device sectors through a custom integration pipeline involving SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms, supported by partnerships with enclosure manufacturers.
Investors and industry observers following TOMZ news will find updates on TOMI’s outreach to cruise lines for advanced maritime decontamination, participation in sector events such as the American Association for Laboratory Animal Science National Meeting, and expansion into animal research and academic markets. The company’s releases also cover financial milestones, including quarterly results, pipeline updates, universal shelf registration filings, equity line of credit arrangements, and Nasdaq listing compliance notices.
This news page aggregates these disclosures, offering a centralized view of TOMI’s commercial projects, strategic relationships, regulatory and financing steps, and sector-focused initiatives involving its SteraMist and BIT-based disinfection technology.
TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) reported its financial results for Q4 and the full year 2021. The company experienced a revenue decline to $7.8 million from $25.0 million in 2020, attributed to reduced demand post-COVID surge. However, revenues rose by 22% compared to pre-pandemic levels in 2019. The second half of 2021 showed a 20% revenue increase over the first half, attributed to business reopening. Gross margin for 2021 was 59.2%. Despite a net loss of $4.4 million, TOMI highlights growth in solution sales and optimism for 2022 based on increased market interest.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) will release its fourth quarter and full-year 2021 financial results on March 29, 2022, after market close. A conference call is scheduled for 4:30 p.m. ET on the same day. Investors can join the call by dialing (877) 545-0320 (entry code 624594) or accessing via the company’s website. A replay will be available until April 12, 2022. TOMI specializes in disinfection solutions utilizing its Binary Ionization Technology through the SteraMist brand, targeting various commercial sectors.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced an urgent shipment of SteraPak units to Tomimist Hong Kong, aimed at combating the COVID-19 Omicron variant outbreak. Daily cases in Hong Kong have surged to over 58,000. The SteraPak units utilize SteraMist iHP technology, enabling effective disinfection in various commercial settings, enhancing productivity and achieving a six-log kill of infectious diseases without harmful side effects. CEO Dr. Halden Shane emphasized TOMI's readiness to support further needs in Hong Kong as the fight against the virus continues.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has partnered with ARM EnerTech Associates to enhance product development and manufacturing capabilities for its SteraMist brand. This collaboration aims to address the growing demand for automated disinfection solutions, particularly through their Custom Engineered Systems (CES). Recent projects have bolstered TOMI's project pipeline, including two CES projects completed in February and one in early March. This partnership is expected to improve competitive positioning and cost efficiencies by diversifying manufacturing capabilities.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced approximately $1.3 million in orders for its Custom Engineered Systems (CES), including contracts with a Fortune 500 pharmaceuticals company and a leading research facility. This demand reflects a surge in cleanroom utilization in the pharmaceutical sector, prompting a shift to automation in disinfection processes. Despite longer lead times for CES installations, TOMI anticipates revenue realization from these orders in late 2022 and early 2023, driven by increasing sales opportunities and a bolstered technical and R&D team.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced a collaboration with On Demand Pharmaceuticals to enhance drug manufacturing through advanced decontamination solutions using TOMI's SteraMist systems. This partnership, leveraging technologies from DARPA, aims to ensure safe production environments in On Demand's modular cleanroom. The Binary Ionization Technology platform provides efficient disinfection, promoting health and safety in pharmaceutical manufacturing. Both companies are committed to innovation in their respective fields, addressing critical needs in health and safety.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced that H.C. Wainwright has initiated analyst coverage of its common stock. This move aims to increase market visibility and enhance the understanding of TOMI's disinfection solutions utilizing its Binary Ionization Technology (BIT). The company emphasizes that analysts' reports reflect their perspectives and not necessarily those of TOMI. The 31-page report is accessible through H.C. Wainwright. TOMI's BIT platform is used widely across various sectors, including healthcare and food processing, underscoring its importance in infection prevention.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has launched the SteraMist Amazon Store, showcasing its SteraPak products utilizing Binary Ionization Technology (BIT). This digital storefront enhances sales channels, making purchasing easier for customers. The SteraPak is designed for various environments, offering efficient disinfection without harmful residues. CEO Dr. Halden Shane emphasized the importance of this initiative in expanding the customer base and protecting against emerging pathogens like the Omicron variant and C. auris fungus.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported Q3 2021 revenues of $2.2 million, a 50% increase from Q2 2021. However, this marked a decline from $4.3 million in Q3 2020. Gross margins fell to 59.6% from 66.0% year-over-year. Operating loss stood at $0.5 million, contrasting with an income of $1.1 million in the same quarter last year. The company's net loss was $0.5 million or $0.03 per share. Recent highlights include expanding their product line with SteraPak and establishing an Amazon store. TOMI remains optimistic for continued growth into Q4 2021 and 2022.
TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) will release its third-quarter financial results after market close on November 12, 2021. A conference call is scheduled for 4:30 p.m. ET to discuss these results. The company specializes in disinfection and decontamination technologies, particularly through its Binary Ionization Technology (BIT) platform and SteraMist product line. The call will be accessible via phone and a live webcast, with a replay available until November 26, 2021.